Alternative Treatments For Small Cell Lung Cancer - Articles

Sort by: Newest Most Comments Relevance

Gefitinib for Non-Small Cell Lung Cancer Trial by Cancer.gov Posted Tue 22 Feb 2011 11:14pm ... Read on »

New therapeutic approaches for small cell lung cancer by Mark Pool, MD Posted Sun 13 Dec 2009 12:00am . Hurwitz J, McCoy F, Scullin P, Fennell D. New advances in the second-line treatment of small cell lung cancer. Oncologist. 2009;14(10):986-994. ... I am currently working on a project with our lung cancer research group at Rush University Medical Center in Chicago in which we are looking at expression Read on »

Chemotherapy and Twice-Daily Radiation Improves Small Cell Lung Cancer Survival by Cancer.gov Posted Tue 22 Feb 2011 11:11pm ... Read on »

Single agent Taxol for relapsed small cell lung cancer by Mark Levin Posted Fri 28 May 2010 4:10pm Small cell lung cancer that progresses after first line chemotherapy has a poor prognosis. A variety of treatments are available, among them single agent Taxol.The... small cell lung cancer.Anticancer Res. 2006 Jan-Feb;26(1B):777-81. Graziano SL, Herndon JE 2nd, Socinski MA, Wang X, Watson D, Vokes E, Green MR; Cancer and Leukemia Group Read on »

Amrubicin for small cell lung cancer by Mark Levin Posted Wed 24 Jun 2009 7:01pm product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy. Amrubicin is being studied in clicnal... Amrubicin, previously known as SM-5887, is an anthracycline used in the treatment of lung cancer. It is marketed in Japan since 2002 by Sumitomo Pharmaceuticals under Read on »

Abraxane caroplatin for non-small cell lung cancer by Mark Levin Posted Sun 27 Feb 2011 1:57pm . Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol 2006;17:1263-1268. Hawkins MJ... of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer. J Clin Oncol 2006;24:395s, Abstract # 7127. Sandler A, Gray Read on »

CT staging of non-small cell lung cancer by Mark Levin Posted Tue 01 Sep 2009 5:31pm In non-small cell lung cancer (NSCLC), the determination of stage is important in terms of therapeutic and prognostic implications. Careful initial diagnostic evaluation... EM, Harpole L, McCrory DC: Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (1 Suppl): 137S-146S, 2003. Gould MK, Kuschner WG Read on »

Non-small Cell Lung Cancer by LungHealth .. Posted Sun 24 Aug 2008 1:49pm . AZZOLI, MD: The most common form of lung cancer is called non-small cell lung cancer. About 15 percent of lung cancer is small cell lung cancer. ANNOUNCER: Lung cancers don't tend to stay put. They often tend to spread, and how they do so is the basis of a system of staging. CHRISTOPHER G. AZZOLI, MD: Non-small cell lung cancer starts in the lung Read on »

ALK Inhibition in Non-Small Cell Lung Cancer and Inflammatory Myofibroblastic Tumor by Mark Pool, MD Posted Thu 28 Oct 2010 9:51pm Great stuff in this week's NEJM! Today's (October 28, 2010) New England Journal of Medicine has no less than three articles reporting the use of small molecule ALK tyrosine kinase inhibitor crizotinib (PF-02341066, Pfizer) in non-small-cell lung cancers harboring the oncogenic fusion gene EML4-ALK and in a patient with ALK-rearrangement Read on »

Alternative Treatment Options for Late Stage Lung Cancer Patients by Wilson N. Posted Sun 07 Mar 2010 7:20am Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients. However, paclitaxel is associated... to receive either 1) paclitaxel plus carboplatin(PC), 2) gemcitabine plus carboplatin(GC) or 3) gemcitabine plus paclitaxel(GP). The results indicated that the alternative treatment Read on »